Palavras-chave
Hanseniasis
Câncer
Localización
Incidencia
Câncer
Localización
Incidencia
Como Citar
1.
WESHLER Z, SHESKIN J. Hanseniasis y cancer. Hansen. Int. [Internet]. 30º de junho de 1983 [citado 14º de novembro de 2024];8(1):18-21. Disponível em: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35583
Resumo
El número de enfermos tratados de hanseniasis y câncer, en Israel, no es suficiente para un análisis estadístico. No se Ilegó todavia a una conclusion general sobre la incidencia de câncer en pacientes de hanseniasis. Los elementos presentados en este trabajo pueden ser utiles para una comparación con aquellos de otros investigadores interesados en el assunto. T.A.E.K.
Referências
1 GOOD, R.A. & FINSTAD, J. Essential relationship between the lymphoid system, immunity, and malignancy. Nat. Cancer Inst. Monogr. (31) :41-58, 1969.
2 KLINGMÜLLER, V. Die Lepra. In: JADASSOHN, J. Handbuch der Haut and Geschlechtskrankheiten. Berlin, Springer, 1930. v.10, pt.2.
3 KOSOLAPKEENA, L.I. & SAVEENICH, B.V. On the problem of malignant neoplasm frequency in lepra patients. Vop. Onkol., 4(1) :90-94, 1958.
4 MICHALANY, J. Malignant tumors of the skin among leprosy patients. Int. J. Lepr., 34(3):274-286, 1966.
5 OLEINICK, A. Altered immunity and cancer risk: a review of the problem and analysis of the cancer mortality experience of leprosy
patients. J. Nat. Cancer Inst., 43(4):775-781, 1969.
6 SOEGARD, M. Weitere Untersuchungen über die Krebssterblichkeit unter den Lepranken. Berlin. Klin. Wschr., 49: 1025-1030, 1912.
7 SOUTHAM, C.M. Relationship of immunology to cancer: a review. Cancer Res., 20(3):271-291, 1960.
8 TURK, J.L. Cell mediated immunological process in leprosy. Bull. Wld. Hlth. Org., 41:779-792, 1969.
9 WESHLER, Z.; LEVIATAN, A.; GORDON, R..; KOPOLOVIC, J. Development of Hodgkin's disease in a patient with leprosy. Oncology,
35:281-284, 1978.
2 KLINGMÜLLER, V. Die Lepra. In: JADASSOHN, J. Handbuch der Haut and Geschlechtskrankheiten. Berlin, Springer, 1930. v.10, pt.2.
3 KOSOLAPKEENA, L.I. & SAVEENICH, B.V. On the problem of malignant neoplasm frequency in lepra patients. Vop. Onkol., 4(1) :90-94, 1958.
4 MICHALANY, J. Malignant tumors of the skin among leprosy patients. Int. J. Lepr., 34(3):274-286, 1966.
5 OLEINICK, A. Altered immunity and cancer risk: a review of the problem and analysis of the cancer mortality experience of leprosy
patients. J. Nat. Cancer Inst., 43(4):775-781, 1969.
6 SOEGARD, M. Weitere Untersuchungen über die Krebssterblichkeit unter den Lepranken. Berlin. Klin. Wschr., 49: 1025-1030, 1912.
7 SOUTHAM, C.M. Relationship of immunology to cancer: a review. Cancer Res., 20(3):271-291, 1960.
8 TURK, J.L. Cell mediated immunological process in leprosy. Bull. Wld. Hlth. Org., 41:779-792, 1969.
9 WESHLER, Z.; LEVIATAN, A.; GORDON, R..; KOPOLOVIC, J. Development of Hodgkin's disease in a patient with leprosy. Oncology,
35:281-284, 1978.
Este periódico está licenciado sob uma Creative Commons Attribution 4.0 International License.
Downloads
Não há dados estatísticos.
